Insigneo Advisory Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04M | Buy |
16,402
+2,940
| +22% | +$546K | 0.26% | 73 |
|
|
2025
Q1 | $2.82M | Buy |
13,462
+50
| +0.4% | +$10.5K | 0.29% | 68 |
|
|
2024
Q4 | $2.38M | Sell |
13,412
-6,870
| -34% | -$1.22M | 0.25% | 78 |
|
|
2024
Q3 | $4.01M | Sell |
20,282
-2,380
| -11% | -$470K | 0.4% | 43 |
|
|
2024
Q2 | $4.18M | Sell |
22,662
-264
| -1% | -$48.7K | 0.47% | 36 |
|
|
2024
Q1 | $4.17M | Buy |
22,926
+1,250
| +6% | +$228K | 0.5% | 35 |
|
|
2023
Q4 | $3.36M | Buy |
21,676
+5,470
| +34% | +$848K | 0.47% | 35 |
|
|
2023
Q3 | $2.42M | Sell |
16,206
-710
| -4% | -$106K | 0.49% | 38 |
|
|
2023
Q2 | $2.28M | Buy |
16,916
+8,090
| +92% | +$1.09M | 0.44% | 46 |
|
|
2023
Q1 | $1.41M | Buy |
8,826
+479
| +6% | +$76.3K | 0.45% | 41 |
|
|
2022
Q4 | $1.35M | Buy |
+8,347
| New | +$1.35M | 0.51% | 42 |
|